Visitor information – Everything you need to know about visiting our sites.
Alfred Health research outcomes are published in a wide range of peer reviewed journals.
Search or browse research publications by year, research area, publication type or keyword.
Publication Details
Long-term treatment outcomes of patients with primary optic nerve sheath meningioma treated with stereotactic radiotherapy
Ratnayake G, Oh T, Mehta R, Hardy T, Woodford K, Haward R, Ruben JD, Dally MJ
(2019), J Clin Neurosci, 68, 162-7
Body size and dietary risk factors for aggressive prostate cancer: a case-control study
Pal M, Hodge AM, Papa N, MacInnis RJ, Bassett JK, Bolton D, Davis ID, Millar J, English DR, Hopper JL, Severi G, Southey MC, Milne RL, Giles GG
(2019), CANCER CAUSE CONTROL, 30(12), 1301-12
Contemporary practice patterns of stereotactic radiosurgery for brain metastasis: A review of published Australian literature
Ong WL, Wada M, Ruben J, Foroudi F, Millar J
(2019), J MED IMAG RADIAT ON, 63(5), 711-20
Forecasting annual incidence and mortality rate for prostate cancer in Australia until 2022 using autoregressive integrated moving average (ARIMA) models
Earnest A, Evans SM, Sampurno F, Millar J
(2019), BMJ Open, 9(8), e031331
Development of a muticentre automated model to reduce planning variability in radiotherapy of prostate cancer
Panettieri V, Ball D, Chapman A, Cristofaro N, Gawthrop J, Griffin P, Herath S, Howly S, Jukes L, Kron T, Markham C, Marr L, Moloney P, Nelli F, Ramachandran P, Smith A, Hornby CJ
(2019), Phys Imaging Radiat Oncol, 11, 39-40
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP, Schellenberg D, Ahmad B, Griffioen G, Senthi S, Swaminath A, Kopek N, Liu M, Moore K, Currie S, Bauman GS, Warner A, Senan S
(2019), Lancet, 393(10185), 2051-8
Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings
Beckmann K, O'Callaghan M, Vincent A, Cohen P, Borg M, Roder D, Evans S, Millar J, Moretti K
(2019), Asian J Urol, 6(4), 321-9
Development of Technologic Solutions to Address Complex Local Requirements of an International Prostate Cancer Clinical Quality Registry
Sampurno F, Kannan A, Lucas M, Liman J, Connor SE, Pearman E, Millar JL, Moore CM, Villanti P, James E, Huland H, Litwin MS, Evans SM
(2019), JCO Clin Can Inform, 3, 1-11
DOI: 10.1200/CCI.18.00114
Improved survival for patients with prostate cancer receiving high-dose-rate brachytherapy boost to EBRT compared with EBRT alone
Kent AR, Matheson B, Millar JL
(2019), Brachytherapy, 18(3), 313-21
A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03)
Wirth A, Prince HM, Roos D, Gibson J, O'Brien P, Zannino D, Khodr B, Stone JM, Davis S, Hertzberg M
(2019), INT J RADIAT ONCOL, 103(5), 1158-66
The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment
Wong Doo N, White VM, Martin K, Bassett JK, Prince HM, Harrison SJ, Jefford M, Winship I, Millar JL, Milne RL, Seymour JF, Giles GG
(2019), Cancers, 11(7), 928
Patterns of end-of-life hospital care for patients with non-Hodgkin lymphoma: exploring the landscape
Philip J, Collins A, Ritchie D, Le B, Millar J, McLachlan SA, Krishnasamy M, Hudson P, Sundararajan V
(2019), LEUKEMIA LYMPHOMA, 60(8), 1908-16
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial
Ball D, Mai GT, Vinod S, Babington S, Ruben J, Kron T, Chesson B, Herschtal A, Vanevski M, Rezo A, Elder C, Skala M, Wirth A, Wheeler G, Lim A, Shaw M, Schofield P, Irving L, Solomon B; TROG 09.02 CHISEL investigators
(2019), Lancet Oncol, 20(4), 494-503
Fractionated Stereotactic Radiotherapy for Cavernous Venous Malformations of the Orbital Apex
Ratnayake GS, McNab AA, Dally MJ, Zajarski C, Senthi S, Ruben JD
(2019), OPHTHAL PLAST RECONS, 35(4), 322-5
Androgen deprivation therapy use with post-prostatectomy radiotherapy in the Prostate Cancer Outcomes Registry Victoria
Ong WL, Foroudi F, Evans S, Millar J
(2019), J MED IMAG RADIAT ON, 61(1), 124-30
The trajectory of patients who die from metastatic prostate cancer: a population-based study
Collins A, Sundararajan V, Millar J, Burchell J, Le B, Krishnasamy M, McLachlan SA, Hudson P, Mileshkin L, Philip J
(2019), BJU Int, 123 Suppl 5, 19-26
DOI: 10.1111/bju.14593
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Tie J, Cohen JD, Wang Y, Li L, Christie M, Simons K, Elsaleh H, Kosmider S, Wong R, Yip D, Lee M, Tran B, Rangiah D, Burge M, Goldstein D, Singh M, Skinner I, Faragher I, Croxford M, Bampton C, Haydon A, Jones IT, S Karapetis C, Price T, Schaefer MJ, Ptak J, Dobbyn L, Silliman N, Kinde I, Tomasetti C, Papadopoulos N, Kinzler K, Volgestein B, Gibbs P
(2019), Gut, 68(4), 663-71
Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy
Beckman K, O'Callaghan M, Vincent A, Roder D, Millar J, Evans S, McNeil J, Moretti K
(2018), ANZ J Surg, 88(3), e183-188
DOI: 10.1111/ans.13954
Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method
Tsiamis E, Millar J, Baxi S, Borg M, De Ieso P, Elsaleh H, Foroudi F, Higgs B, Holt T, Martin J, Moretti K, Pryor D, Skala M, Evans S
(2018), Radiother Oncol, 128(2), 308-14
An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging
Smith RL, Hanlon M, Panettieri V, Millar JL, Matheson B, Haworth A, Franich RD
(2018), Brachytherapy, 17(1), 111-121